Cyclerion Therapeutics In... (CYCN)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
2.42
-0.29 (-10.70%)
At close: Jan 28, 2025, 3:59 PM
2.45
1.13%
After-hours Jan 28, 2025, 04:00 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Cash & Equivalents | 7.57M | 13.38M | 53.96M | 54.40M | 94.89M | n/a | n/a |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 5.35M | n/a | n/a | 3.84M | 4.99M | n/a | n/a |
Other Long-Term Assets | n/a | 2.04M | 2.41M | 2.77M | 540.00K | 25.00K | 80.00K |
Receivables | n/a | 96.00K | 100.00K | 127.00K | 1.47M | n/a | n/a |
Inventory | n/a | 805.00K | 928.00K | 816.00K | 1.97M | n/a | n/a |
Other Current Assets | 453.00K | 1.34M | 1.40M | 3.98M | 4.83M | 879.00K | 1.26M |
Total Current Assets | 8.02M | 14.82M | 55.46M | 58.50M | 101.20M | 879.00K | 1.26M |
Property-Plant & Equipment | n/a | 1.22M | 1.47M | 50.27M | 79.75M | 6.50M | 4.13M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 5.35M | 3.26M | 3.87M | 56.88M | 85.28M | 6.52M | 4.21M |
Total Assets | 13.37M | 18.08M | 59.33M | 115.38M | 186.48M | 7.40M | 5.47M |
Account Payables | 1.20M | 2.97M | 1.83M | 1.44M | 3.31M | 2.78M | 1.80M |
Deferred Revenue | n/a | n/a | n/a | 8.54M | 11.11M | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | 6.80M | 6.84M | n/a | n/a |
Other Current Liabilities | 888.00K | 4.66M | 9.26M | 8.71M | 8.10M | 15.06M | 12.23M |
Total Current Liabilities | 2.09M | 7.63M | 11.09M | 16.95M | 18.25M | 17.85M | 14.04M |
Long-Term Debt | n/a | n/a | n/a | 38.93M | 70.50M | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | n/a | 2.97M | n/a | 38.93M | 70.50M | n/a | n/a |
Total Liabilities | 2.09M | 7.63M | 11.09M | 55.88M | 88.75M | 17.85M | 14.04M |
Total Debt | n/a | n/a | n/a | 45.73M | 73.92M | n/a | n/a |
Common Stock | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Retained Earnings | -264.42M | -259.15M | -215.08M | -163.43M | -85.63M | n/a | n/a |
Comprehensive Income | -12.00K | -20.00K | -23.00K | -27.00K | -20.00K | -15.49M | -15.87M |
Shareholders Equity | 11.29M | 10.45M | 48.25M | 59.49M | 97.73M | -10.45M | -8.57M |
Total Investments | 5.35M | n/a | n/a | 3.84M | 4.99M | n/a | n/a |